Announcements

Talking university spin-outs – University of Warwick
Psioxus Launches Phase I/II Clinical Trial Of Oncolytic Vaccine With Dosing Of Patient With Metastatic Colorectal Cancer
Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust
Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award
Pro Bono Bio obtains exclusive licence from PolyTherics
Looking at university spin-outs: University of Birmingham
PolyTherics appoints new head of business development
Hybrid SEIS scheme investment fund launched – the Mercia Growth Fund
PolyTherics granted further patents for TheraPEG and GlycoPol
Allinea DDT the debugger of choice for the worlds most powerful supercomputer.